Mylan announced the launch of Naloxone HCl Injection USP, the bioequivalent of Hospira’s Naloxone HCl Injection.

Naloxone HCl Injection is a narcotic antagonist indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics.

RELATED: Poisoning & Drug Dependence Resource Center

Mylan’s Naloxone HCl Injection is available in a 0.4mg/mL strength packaged in 1mL single-dose vials. It is preservative-free and not made with natural rubber latex.

For more information call (800) 796-9526 or visit